Drug class in one race
IL-17 drugs for Psoriasis
4 tracked IL-17 drugs in the Psoriasis race. The class explanation lives on the IL-17 page; the full indication pipeline across every mechanism is on the Psoriasis page.
2 approved / phase 42 Phase 3
Head-to-head evidence: ixekizumab vs netakimab · ixekizumab vs secukinumab · ixekizumab vs vunakizumab · netakimab vs secukinumab · netakimab vs vunakizumab · secukinumab vs vunakizumab